The rise of replication

Hedge fund replication was the talk of financial markets at the end of last year. Sadly, confusion about what the strategy entails, plus inaccurate media reports, left many investors scratching their heads. But Daniel Sheehan finds that hedge fund clones could present exciting opportunities for structured products marketers

US investment bank Goldman Sachs and rival Merrill Lynch created something of a buzz in financial markets at the end of 2006 when they unveiled their hedge fund replication strategies. At the time, it was widely reported that replication strategies could present a threat to direct investment into hedge funds. Both banks say this is untrue, but they believe replication is an important leap forward for structured products creation.

Replication models effectively say that historical hedge fund

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@risk.net or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact info@risk.net to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Risk.net? View our subscription options

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here